Biomarker Lens

Biomarkers · Chemical

Neurofilament Light Chain

Understand what Neurofilament Light Chain signals

Primary unit
pg/mL
LOINC codes
101281-4
Commercial laboratory assays
5

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Neurofilament Light Chain

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

ATN Profile

Laboratory
Labcorp
Test code
484400
Specimen
Plasma
Fasting
Not stated
Turnaround
7 - 10 days

Laboratory assay overview

This profile is used to assist in determining the presence or absence of key biological changes that are consistent with Alzheimer's disease pathology.

Labcorp test directory, test code 484400

Multiple Sclerosis Monitoring Profile

Laboratory
Labcorp
Test code
484495
Specimen
Serum
Fasting
Not stated
Turnaround
1 - 3 days

Laboratory assay overview

This test is used to monitor Neurofilament Light Chain, Serum (NfL) and Glial Fibrillary Acid Protein, Serum (GFAP) values in multiple sclerosis patients.

Labcorp test directory, test code 484495

Neurofilament Light Chain (NfL)

Laboratory
Quest Diagnostics
Test code
13979
Specimen
Plasma
Fasting
Not stated
LOINC
101281-4
Turnaround
Set up: Mon, Wed-Sat

Laboratory assay overview

Neurofilament light (NfL) is an intermediate filament protein found specifically in the neuronal cytoskeleton. It can be released into the extracellular space through axonal degradation, and it has been shown that varying NfL levels are an indicator of neuroaxonal damage, irrespective of the cause, and can therefore be associated with a variety of neurological diseases such as multiple sclerosis, amyotrophic lateral sclerosis, frontotemporal dementia, or Alzheimer's disease, as well as acute situations such as traumatic brain injury and others. NfL is thus considered a promising biomarker for, e.g. disease activity, progression, prognosis, and monitoring effectiveness of therapies. As NfL can be measured in both cerebrospinal fluid (CSF) and blood, it holds great potential for routine clinical use.

Quest Diagnostics population reference ranges

Quest Diagnostics calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.

PopulationRange
<20 yearsNot established
20-29 years<1.17 pg/mL
30-39 years<1.29 pg/mL
40-49 years<2.34 pg/mL
50-59 years<2.21 pg/mL
60-69 years<3.86 pg/mL
70-79 years<5.27 pg/mL
≥80 years<7.05 pg/mL
View complete laboratory reference notes

<20 years | Not established 20-29 years | <1.17 pg/mL 30-39 years | <1.29 pg/mL 40-49 years | <2.34 pg/mL 50-59 years | <2.21 pg/mL 60-69 years | <3.86 pg/mL 70-79 years | <5.27 pg/mL ≥80 years | <7.05 pg/mL

Quest Diagnostics test directory, test code 13979

Neurofilament Light Chain, Plasma

Laboratory
Labcorp
Test code
140555
Specimen
Plasma
Fasting
Not stated
LOINC
101281-4
Turnaround
1 - 3 days

Laboratory assay overview

This test is used for the measurement of the level of Neurofilament Light Chain in plasma.

Labcorp population reference ranges

Labcorp calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.

PopulationRange
Age (y)(pg/mL)
0 to 4 y0.00–1.56
5 to 9 y0.00–1.30
10 to 14 y0.00–1.13
15 to 19 y0.00–1.26
20 to 29 y0.00–1.30
30 to 39 y0.00–1.49
40 to 49 y0.00–1.69
50 to 59 y0.00–2.99
60 to 69 y0.00–3.65
70 to 79 y0.00–6.04
>79 y0.00–9.13
View complete laboratory reference notes

See table. Age (y) | (pg/mL) 0 to 4 y | 0.00–1.56 5 to 9 y | 0.00–1.30 10 to 14 y | 0.00–1.13 15 to 19 y | 0.00–1.26 20 to 29 y | 0.00–1.30 30 to 39 y | 0.00–1.49 40 to 49 y | 0.00–1.69 50 to 59 y | 0.00–2.99 60 to 69 y | 0.00–3.65 70 to 79 y | 0.00–6.04 >79 y | 0.00–9.13

Labcorp test directory, test code 140555

Neurofilament Light Chain, Serum

Laboratory
Labcorp
Test code
140455
Specimen
Serum
Fasting
Not stated
LOINC
101281-4
Turnaround
1 - 3 days

Laboratory assay overview

This test is used for the measurement of the level of Neurofilament Light Chain in serum.

Labcorp population reference ranges

Labcorp calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.

PopulationRange
Age (y)(pg/mL)
0 to 4 y0.00–1.56
5 to 9 y0.00–1.30
10 to 14 y0.00–1.13
15 to 19 y0.00–1.26
20 to 29 y0.00–1.30
30 to 39 y0.00–1.49
40 to 49 y0.00–1.69
50 to 59 y0.00–2.99
60 to 69 y0.00–3.65
70 to 79 y0.00–6.04
>79 y0.00–9.13
View complete laboratory reference notes

See table. Age (y) | (pg/mL) 0 to 4 y | 0.00–1.56 5 to 9 y | 0.00–1.30 10 to 14 y | 0.00–1.13 15 to 19 y | 0.00–1.26 20 to 29 y | 0.00–1.30 30 to 39 y | 0.00–1.49 40 to 49 y | 0.00–1.69 50 to 59 y | 0.00–2.99 60 to 69 y | 0.00–3.65 70 to 79 y | 0.00–6.04 >79 y | 0.00–9.13

Labcorp test directory, test code 140455

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.